COMMUNIQUÉS West-GlobeNewswire

Omada Health’s Enhanced GLP-1 Care Track Demonstrates Increased Medication Persistence and Weight Loss Outcomes at 12 and 24 Weeks
17/06/2025
New GLP-1 analysis reveals that by addressing real-world barriers to persistence, Omada’s companion program can help sustain GLP-1 use, delivering on clinical trials' promises SAN FRANCISCO, June 17, 2025 (GLOBE [...]
Project Sunshine Announces "Longest Day of Play" Fundraising Campaign Planned for June 20th Alongside Refreshed Visual Identity
17/06/2025
NEW YORK, June 17, 2025 (GLOBE NEWSWIRE) -- Project Sunshine , an organization supporting children and families with medical needs through the power of play, is launching a major fundraising campaign on Friday, June [...]
BioRestorative Announces Share Repurchase Program
17/06/2025
MELVILLE, N.Y., June 17, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc . (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ: BRTX ) , a clinical stage regenerative medicine innovator focused on stem cell-based [...]
Prime Biome Gummy: Examining the Science and Safety of a Legal Gut-Skin Health Formula
17/06/2025
LARGO, Fl, June 17, 2025 (GLOBE NEWSWIRE) -- Amid rising interest in gut health and its connection to overall wellness, a new supplement called Prime Biome Gummy has entered the market, offering a science-based approach [...]
FDA Grants Orphan Drug Designation to Medicovestor’s First-in-Class ADC for Pancreatic Cancer
17/06/2025
Novel chemoimmunotherapy platform aims to transform outcomes in one of the world’s deadliest cancers NEW YORK, June 17, 2025 (GLOBE NEWSWIRE) -- Medicovestor , Inc., a biotechnology company advancing next-generation [...]
USAHS & The Brain Center Unite to Support Dementia Caregivers with Hands-On Course
17/06/2025
The event offers immersive training and emotional support for family caregivers during Alzheimer’s & Brain Awareness Month. MIAMI, June 17, 2025 (GLOBE NEWSWIRE) -- In recognition of Alzheimer’s & Brain [...]
Lauréat de l’appel à projet Biothérapies et Bioproduction, du plan France 2030, EVerZom reçoit un financement de l’Etat de 3 millions d’euros pour industrialiser sa technologie de bioproduction d’exosomes
17/06/2025
Lauréat de l’appel à projet Biothérapies et Bioproduction, du plan France 2030, EVerZom reçoit un financement de l’Etat de 3 millions d’euros pour industrialiser sa technologie de bioproduction d’exosomes Paris, le 17 [...]
Winner of the “Biotherapies and Bioproduction” call for projects under the France 2030 plan, EVerZom receives €3 million in government funding to industrialize its exosome bioproduction technology
17/06/2025
Winner of the “Biotherapies and Bioproduction” call for projects under the France 2030 plan, EVerZom receives €3 million in government funding to industrialize its exosome bioproduction technology Paris, June 17, 2025 [...]
Astrocyte Pharmaceuticals Announces Milestones in the Fight Against Concussions: Launch of Phase 2 Clinical Trial and New $3M NIH Grant
17/06/2025
GROTON, Conn., June 17, 2025 (GLOBE NEWSWIRE) -- Astrocyte Pharmaceuticals Inc. , a clinical-stage biotechnology company today announced two major milestones that could change the way we protect brains from the damage [...]
AscellaHealth Wins Business Change and Transformation Excellence Award at the Industry Eagles Awards 2025
17/06/2025
DUBLIN and BERWYN, Pa., June 17, 2025 (GLOBE NEWSWIRE) -- We are proud to announce that AscellaHealth has been awarded Gold in the Business Change and Transformation Excellence category at the Industry Eagles Awards [...]
Immuneering Reports Positive Overall Survival Data for Atebimetinib (IMM-1-104) from Ongoing Phase 2a Trial in First-Line Pancreatic Cancer Patients
17/06/2025
- 94% OS and 72% PFS observed at 6 months for atebimetinib (IMM-1-104) in combination with modified Gemcitabine/nab-paclitaxel (mGnP), N=34; median OS and PFS not yet reached - - Striking tumor reductions with 39% [...]
Serina Therapeutics Congratulates Juvenescence Ltd. on $150M Series B Funding and Strategic Partnership with M42
17/06/2025
HUNTSVILLE, June 17, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform ™ drug optimization technology, [...]
Tariffs and U.S.-Canada relations are the top financial concern for seniors: new research from HOOPP and Abacus Data
17/06/2025
TORONTO, June 17, 2025 (GLOBE NEWSWIRE) -- Geopolitical instability and the ongoing trade dispute with the United States have emerged as a major financial concern for Canadians and is having an impact on people’s [...]
Lyell Immunopharma Announces Positive New Clinical Data Demonstrating High Rates of Durable Complete Responses from the Phase 1/2 Trial of LYL314 for the Treatment of Aggressive Large B-cell Lymphoma
17/06/2025
LYL314 demonstrated robust clinical responses, with an 88% overall response rate and a 72% complete response rate in patients treated in the third- or later-line setting (N = 25) 71% of patients with complete response [...]
Microbix Attending & Presenting at Asia Pacific POC 2025
17/06/2025
Showcasing Global Utility of its QAPs at Point-of-Care Testing Conference MISSISSAUGA, Ontario, June 17, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix ® ), a life sciences [...]
Tisento Therapeutics Receives U.S. FDA Fast Track Designation for Zagociguat for the Treatment of MELAS
17/06/2025
Global Phase 2b PRIZM Study of Zagociguat is Currently Enrolling Participants with MELAS CAMBRIDGE, Mass., June 17, 2025 (GLOBE NEWSWIRE) -- Tisento Therapeutics today announced that the U.S. Food and Drug [...]
ProMIS Neurosciences Presents at H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference
17/06/2025
Webcast of virtual fireside chat today, June 17th, at 7:00 a.m. ET CAMBRIDGE, Massachusetts, June 17, 2025 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company committed to [...]
Mineralys Therapeutics Announces Positive Topline Results from Phase 2 Explore-CKD Trial of Lorundrostat for the Treatment of Hypertension in Subjects with CKD and Albuminuria
17/06/2025
– Explore-CKD met its primary endpoint; lorundrostat 25 mg once daily achieved a 9.3 mmHg reduction in systolic blood pressure, and a 7.5 mmHg placebo-adjusted reduction (p=0.0024) at four weeks – – Lorundrostat showed [...]
Oncocyte Changes Name to Insight Molecular Diagnostics Inc. (iMDx), Moves Headquarters to Nashville
17/06/2025
New name aligns with mission to deliver precision biomarker-based testing for both transplant and oncology care iMDx sponsoring GraftAssureIQ™ research-use-only kits at transplant labs globally Exhibiting at European [...]

Pages